ArticleJournal of inflammation research2021

LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson's Disease.

Youcui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.